CIK 0001130598 · Non-accelerated filer<br>Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | CAUTREELS WERNER Director | Grant or award | +4,874 | 109,222 | ||
| 2025-12-12 | CAUTREELS WERNER Director | Grant or award · Stock Option (right to purchase) | +19,496 | 19,496 | ||
| 2025-12-12 | STOVER JACK E Director | Grant or award | +6,157 | 6,165 | ||
| 2025-12-12 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +24,629 | 24,629 | ||
| 2025-11-21 | Leaman John Harold Director | Grant or award · Stock Option (right to purchase) | +12,770 | 12,770 | ||
| 2025-10-12 | Parker Charles Nolan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +32,406 | 32,406 | ||
| 2025-10-12 | Redfield Robert Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +32,406 | 32,406 | ||
| 2025-10-12 | Pauza Charles David Chief Science Officer Virology | Grant or award · Stock Option (right to purchase) | +32,406 | 32,406 | ||
| 2025-10-12 | Savchuk Nikolay Chief Operating Officer | Grant or award · Stock Option (right to purchase) | +22,435 | 22,435 | ||
| 2025-10-12 | Clarke Trafford Director | Grant or award · Stock Option (right to purchase) | +11,530 | 11,530 | ||
| 2025-10-12 | Shoemaker Mary Teresa Director | Grant or award · Stock Option (right to purchase) | +11,530 | 11,530 | ||
| 2025-10-12 | Dukes Iain D. Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +64,839 | 64,839 | ||
| 2025-10-12 | CAUTREELS WERNER Director | Grant or award · Stock Option (right to purchase) | +11,530 | 11,530 | ||
| 2025-10-12 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +11,530 | 11,530 | ||
| 2025-10-01 | Leaman John Harold Director | Grant or award · Stock Option (right to purchase) | +15,609 | 15,609 | ||
| 2025-06-19 | Clarke Trafford Director | Grant or award · Stock Option (right to purchase) | +23,000 | 23,000 | ||
| 2025-06-19 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +23,000 | 23,000 | ||
| 2025-06-19 | Shoemaker Mary Teresa Director | Grant or award · Stock Option (right to purchase) | +23,000 | 23,000 | ||
| 2025-06-19 | CAUTREELS WERNER Director | Grant or award · Stock Option (right to purchase) | +23,000 | 23,000 | ||
| 2025-04-02 | TPAV, LLC 10% owner | Other disposition | −605,531 | 0 |
Page 3 of 9 · 170 trades